Cited by

• Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group.

  Scholz H, Noack R. Scholz H, et al. Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):470-8. doi: 10.1007/BF01691129. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9764549 Clinical Trial.
• Time to negative throat culture following initiation of antibiotics for pharyngeal group A Streptococcus: a systematic review and meta-analysis up to October 2021 to inform public health control measures.

  McGuire E, Li A, Collin SM, Decraene V, Cook M, Padfield S, Sriskandan S, Van Beneden C, Lamagni T, Brown CS. McGuire E, et al. Euro Surveill. 2023 Apr;28(15):2200573. doi: 10.2807/1560-7917.ES.2023.28.15.2200573. Euro Surveill. 2023. PMID: 37052678 Free PMC article.
• Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.

  Adam D, Scholz H. Adam D, et al. Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):712-7. doi: 10.1007/BF01691957. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8922570 Clinical Trial.
• Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.

  Croteau D, Bergeron MG, LeBel M. Croteau D, et al. Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561. Antimicrob Agents Chemother. 1988. PMID: 3259856 Free PMC article. Clinical Trial.
• Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.

  Bérubé D, Kirouac D, Croteau D, Bergeron MG, Lebel M. Bérubé D, et al. Antimicrob Agents Chemother. 1988 Aug;32(8):1227-30. doi: 10.1128/AAC.32.8.1227. Antimicrob Agents Chemother. 1988. PMID: 3142349 Free PMC article. Clinical Trial.